International generics companies do not deny clinical trial fraud in India
International generic pharmaceutical companies and contract research organisations working in India may be producing unreliable data to support their products, according to a new report from Reuters. At least one international company, Novartis, says that it is stepping up its own checks. “We can’t rely on the regulators … we’re increasing our own audits,” …
International generics companies do not deny clinical trial fraud in India Read More »
